参考文献/References:
[1] Graber TG,Fry CS,Brightwell CR,et al.Skeletal muscle-specific knockout of DEP domain containing 5 protein increases mTORC1 signaling,muscle cell hypertrophy,and mitochondrial respiration[J].J Biol Chem,2019,15:29411.
[2] Iffland PH,Baybis M,Barnes AE,et al.DEPDC5 and NPRL3 modulate cell size,filopodial outgrowth,and localization of mTOR in neural progenitor cells and neurons[J].Neurobiol Dis,2018,6:114-121.
[3] Neligan A,Bell GS,Johnson AL,et al.The long term risk of premature mortality in people with epilepsy[J].Brain,2011,134(2):388-395.
[4] Ribierre T,Deleuze C,Bacq A,et al.Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasiaassociated epilepsy[J].J Clin Invest,2018,128(6):2452-2458.
[5] 陈丽卿,刘 艳.DEPDC5基因突变相关婴儿痉挛3例报告及文献复习[J].临床儿科杂志,2019,37(9):669-681.
[6] Zhao Y,Schoeps B,Yao D,et al.mTORC1 and mTORC2 converge on the Arp2/3 complex to promote Kras-induced acinar-to-ductal metaplasia and early pancreatic carcinogenesis[J].Gastroenterology,2021,5085(20):35626-35628.
[7] Maskey RS,Wang F,Lehman E,et al.Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells[J].Cell Cycle,2020,12:11-16.
[8] Luo W,Zhang H,Zhang Y,et al.L-type amino acid transporter 1 promotes proliferation and invasion of human chorionic trophoblast and choriocarcinoma cells through mTORC1[J].Am J Transl Res,2020,12(10):6665-6681.
[9] Hai H,Tamori A,Thuy LTT,et al.Polymorphisms in MICA,but not in DEPDC5,HCP5 or PNPLA3,are associated with chronic hepatitis C-related hepatocellular carcinoma[J].Sci Rep,2017,71(1):11912-11921.
[10] Miki D,Ochi H,Hayes CN,et al.Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers[J].Nat Genet,2011,43(8):797-800.
[11] Liu W,Ma N,Zhao D,et al.Correlation between the DEPDC5 rs1012068 polymorphism and the risk of HBV-related hepatocellular carcinoma[J].Clinics and Research in Hepatology and Gastroenterology,2019,43(4):446-450.
[12] Pang Y,Xie F,Cao H,Wang C,et al.DEPDC5 Mutational inactivation of mTORC1 repressor genein human gastrointestinal stromal tumors[J].Proc Natl Acad Sci USA,2019,116(45):22746-22753.
[13] Padi SKR,Singh N,Bearss JJ,et al.Phosphorylation of DEPDC5,a component of the GATOR1 complex,releases inhibition of mTORC1 and promotes tumor growth[J].Proc Natl Acad Sci,2019,116(41):20505-20510.
[14] 馨 娅.发现胃肠道间质瘤恶性进展的新机制[J].科学,2019,71(6):62.
[15] Shen K,Huang RK,Brignole EJ,et al.Architecture of the human GATOR1 and GATOR1-Rag GTPases complexes[J].Nature,2018,556(7699):64-69.
[16] Jacinto E,Loewith R,Schmidt S,et al.Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive[J].Nature Cell Biology,2004,6(11):1122-1128.
[17] Chan EY.mTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex[J].Sci Signal,2009,2(84):51.
[18] Cargnello M,Tcherkezian J,Roux PP.The expanding role of mTOR in cancer cell growth and proliferation[J].Mutagenesis,2015,30(2):169-176.
[19] Chaube UJ,Rawal R,Jha AB,et al.Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer[J].Bioorg Chem,2021,106(1):104501.
[20] Klofas LK,Short BP,Snow JP,et al.DEPDC5 haploinsufficiency drives increased mTORC1 signaling and abnormal morphology in human iPSC-derived cortical neurons[J].Neurobiol Dis,2020,143(9):104975.
[21] Yuskaitis CJ,Rossitto LA,Gurnani S,et al.Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal DEPDC5 loss in mice[J].Hum Mol Genet,2019,28(17):2952-2964.
[22] 刘彩霞.DEPDC5基因多态性与乙型肝炎病毒相关肝细胞癌易感性的研究[D].济南:山东大学,2014.
[23] 马 宁.候选基因多态性对HBV感染及其结局的影响[D].石家庄:河北医科大学,2012.
相似文献/References:
[1]吴 戈,蔡 瑜△,贾媛媛,等.塞来昔布联合化疗治疗晚期胃癌疗效与安全性Meta分析*[J].陕西医学杂志,2020,49(3):364.
WU Ge,CAI Yu,JIA Yuanyuan,et al.Efficacy and safety of celecoxib combined with chemotherapy versus chemortherapy alone in the treatment of advanced gastric cancer:a meta-analysis[J].,2020,49(5):364.
[2]吴水清,李达周△,龚清全,等.福建宁德地区慢性萎缩性胃炎与幽门螺旋杆菌感染情况调查研究[J].陕西医学杂志,2020,49(6):763.[doi:DOI:10.3969/j.issn.10007377.2020.06.031]
[3]苏保伟,王景杰△.胆汁反流性胃炎发病机制及其肠化生分子作用机制研究进展*[J].陕西医学杂志,2020,49(9):1198.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.038]
SU Baowei,WANG Jingjie..Pathogenesis of bile reflux gastritis and molecular mechanism of intestinal metaplasia[J].,2020,49(5):1198.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.038]
[4]张筱东,谢星星△,张正祥,等.胃癌循环肿瘤细胞膜滤过分离技术检测及其与临床病理特征关系研究[J].陕西医学杂志,2020,49(12):1684.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.039]
ZHANG Xiaodong,XIE Xingxing,ZHANG Zhengxiang,et al.Detection of circulating tumor cells in gastric cancer by membrane filtration and its correlation with clinicopathological features[J].,2020,49(5):1684.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.039]
[5]宋香妮,陈瑶莉,杨 剑,等.卷曲蛋白8在胃癌BGC823细胞中的表达及其对胃癌细胞迁移、侵袭的影响[J].陕西医学杂志,2021,50(3):285.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.007]
SONG Xiangni,CHEN Yaoli,YANG Jian,et al.Expression of FZD8 in gastric cancer BGC823 cells and its effect on migration and invasion of gastric cancer cells[J].,2021,50(5):285.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.007]
[6]申辽辽,贺 丽.血浆纤维蛋白原、血小板计数检测在胃癌诊断与预后评估中的临床意义[J].陕西医学杂志,2021,50(4):489.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.028]
[7]牛根亮,曹 波.双源CT双能扫描动脉期碘浓度及Overlay值对伴淋巴结转移的胃癌组织学分级鉴别价值[J].陕西医学杂志,2021,50(8):954.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.013]
NIU Genliang,CAO Bo.Value of iodine concentration and Overlay value in arterial phase scanned by dual-source CT in differentiation of histological grading of gastric cancer[J].,2021,50(5):954.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.013]
[8]李向阳,任 磊,梁 瑞.血清基质金属蛋白酶-9、基质金属蛋白酶-2水平对胃癌腹膜转移及预后的预测价值[J].陕西医学杂志,2023,52(2):166.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.011]
[9]钟 爽,罗 慧,施智兰,等.胆汁酸、幽门螺旋杆菌等因素诱导尾型同源盒转录因子2表达致胃黏膜肠上皮化生研究进展[J].陕西医学杂志,2023,52(6):771.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.030]
ZHONG Shuang,LUO Hui,SHI Zhilan,et al.Research progress of CDX2 expression induced by bile acid,Helicobacter pylori and other factors in gastric intestinal metaplasia[J].,2023,52(5):771.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.030]
[10]法良玲,孙 伟,黄 臻.长链非编码RNA 00941、微小RNA-145表达及转化生长因子β1/Smad通路相关因子在胃癌组织中的表达及意义[J].陕西医学杂志,2024,(10):1416.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.026]
FA Liangling,SUN Wei,HUANG Zhen.Expression and significance of Linc00941,miR-145 and TGF-β1/Smad pathway-related factors in gastric cancer[J].,2024,(5):1416.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.026]